DLD Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$138K 230
2022
Q2
$138K Buy
+10,000
New +$160K 0.01% 206
2022
Q1
Sell
-250,000
Closed -$4.07M 239
2021
Q4
$4.07M Buy
250,000
+24,800
+11% +$418K 0.22% 64
2021
Q3
$3.35M Buy
+225,200
New +$3.6M 0.24% 59
2020
Q3
Sell
-65,000
Closed -$3.11M 92
2020
Q2
$3.11M Buy
65,000
+1,800
+3% +$139K 0.14% 48
2020
Q1
$3.97M Buy
+63,200
New +$5.68M 0.25% 45
2019
Q3
Sell
-15,000
Closed -$1.19M 92
2019
Q2
$1.19M Sell
15,000
-1,434,900
-99% -$128M 0.05% 69
2019
Q1
$162M Buy
1,449,900
+615,300
+74% +$67.2M 5.97% 5
2018
Q4
$84.1M Buy
834,600
+341,600
+69% +$35.4M 5.77% 6
2018
Q3
$62.3M Buy
493,000
+364,000
+282% +$38.5M 3.08% 7
2018
Q2
$10.8M Buy
+129,000
New +$9.45M 0.82% 31

Other funds holding ICPT